Alternate Day Buprenorphine Administration, Phase IX - 14



Status:Completed
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:22 - 51
Updated:5/7/2016
Start Date:March 1992

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Alternate Day Buprenorphine Administration, Phase IX

The purpose of this study is to determine if four times a subjects' daily maintenance dose
will hold for 120 hours without changes in agonist and antagonist effects.


Please contact site for information.
We found this trial at
1
site
Treatment Research Center
Burlington, Vermont 05401
?
mi
from
Burlington, VT
Click here to add this to my saved trials